Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects.

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

Movember is the name given to the facial hair campaign that takes place each year during November, Movember is responsible for the sprouting of moustaches on thousands of men’s faces in the around the world, the aim is simply to raise vital funds and awareness for men’s health, more specifically prostate cancer and testicular cancer.